DMC Biotechnologies is creating sustainable chemical products using precision microbe fermentation. To achieve this, DMC is using their Dynamic Metabolic ControlTM technology platform, which combines a standardized 2-stage fermentation process with varying gene silencing and targeted proteolysis to create a genetic network optimized for the necessary product formation. The technology limits the ability of the microbes to respond to varying external changes ensuring a standard process independent of the required product. In this manner, DMC has a modular, scalable and robust bioprocess that can make multiple products with unparalleled speed overcoming major limitations in biotechnology commercialisation.

DMC Biotechnologies

Founded: 2014
Location: Boulder, CO
Employee range: 1-50
Funding: 50-100M

Short description:

Drug notes:

Long description:

Jobs: